US Pneumococcal Vaccine Market Projected to Reach $6,511.79 Million by 2034, Growing at a CAGR of 2.3%

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
• The US pneumococcal vaccine market size was valued at USD 5,239.27 million in 2024.
• The market is expected to grow at a CAGR of 2.3% from 2025 to 2034.
• This market is expected to grow to USD 6511.79 million by 2034.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Pneumonia is a lung infection that makes breathing difficult by causing the lungs' air sacs to fill with pus or fluid. One of the leading causes of pneumonia is infection by Streptococcus pneumoniae bacteria, which belongs to the genus Streptococcus and is a spherical, alpha-hemolytic, Gram-positive bacterium. S. pneumoniae cells are typically found in pairs, are not motile, and do not produce spores. The bacterium Streptococcus pneumoniae, which can cause sepsis, meningitis, and pneumonia, is prevented by a pneumococcal vaccine. It is far safer to get vaccinated against pneumococcal disease than to contract the disease.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://polarismarketresearch.com/industry-analysis/us-pneumococcal-vaccine-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:
• The US pneumococcal vaccine market is expanding as a result of rising public health awareness and the use of licensed vaccines that have received FDA approval.
• The market is driven by the robust distribution network of the US and the high prevalence of pneumococcal infections.
• Due to their much higher risk of contracting the disease, the growing number of elderly people in the US is driving up the demand for pneumococcal vaccinations.
• Vaccination coverage for adults and children has increased thanks to government vaccination programs and advice from public health organizations like the CDC, which are further boosting the US pneumococcal vaccine market.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
A few of the major players that are influencing the growth of the market are:
• Pfizer Inc.
• Merck & Co., Inc.
• Sanofi
• GlaxoSmithKline plc
• CSL Behring
• Serum Institute
• Astellas Pharma US, Inc.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
https://www.polarismarketresearch.com/buy/4183/0

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:
• The US pneumococcal vaccine market is segmented based on end use, product type, and vaccine type.
• Based on the vaccine type segment, the largest revenue share is held by the pneumococcal polysaccharide vaccine (PPV) segment. This domination is because of its use for both the old-age population and children with weaker immune systems.
• The growing number of pneumococcal diseases and the strong support and initiatives from regulatory bodies like the FDA are also expected to contribute to the significant growth of the pneumococcal conjugate vaccine (PCV) segment in the coming years.

US Pneumococcal Vaccine Market, Product Type Outlook
• Prevnar 13
• Synflorix
• Pneumovax23

US Pneumococcal Vaccine Market, Vaccine Type Outlook
• Pneumococcal conjugate vaccine (PCV)
• Pneumococcal polysaccharide vaccine (PPV)

US Pneumococcal Vaccine Market, End Use Outlook
• Public Sector
• Private Sector

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/us-pneumococcal-vaccine-market

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Transcatheter Aortic Valve Replacement (Tavr) Market
https://www.polarismarketresearch.com/industry-analysis/transcatheter-aortic-valve-replacement-tavr-market

Airway Management Devices Market
https://www.polarismarketresearch.com/industry-analysis/airway-management-devices-market

Alzheimer's Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/alzheimers-therapeutics-market

Artificial Tendons and Ligaments Market
https://www.polarismarketresearch.com/industry-analysis/artificial-tendons-and-ligaments-market

Targeted Protein Degradation Market
https://www.polarismarketresearch.com/industry-analysis/targeted-protein-degradation-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.